stocks
CAPLIPOINT

Caplin Point Laboratories Ltd.

2,612.20-59.3 (-2.22%)
17 Jul, 12:00 AM

Stock Scores

Quality Score

92.3 / 100

Value Score

33.8 / 100

Price Momentum Score

93.5 / 100

QVM Score

92.1 / 100

Key Metrics

Market Cap
19855.90
P/E (TTM)
30.96
P/B
5.54
P/S (TTM)
9.08
EV/EBITDA
24.68
CAPE (5Y)
43.15
ROE (TTM)
19.89
ROCE (TTM)
21.05
ROA (TTM)
17.68
Avg 3Y ROE
20.42
Earnings 3Y CAGR
19.59
Sales 3Y CAGR
14.25
Sales 5Y CAGR
15.56
Debt/Equity
0.00
Consensus TP
2505.00
Strong Buy %
-
Promoter Holding
70.57
Pledged %
0.00

Share Price

Track Caplin Point Laboratories Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 1.11 %
Low
2,563.2
High
2,700.0
1 Month returns: 11.36 %
Low
2,338.8
High
2,700.0
1 Year returns: 23.83 %
Low
1,500.3
High
2,700.0
3 Year CAGR: 43.62 %
Low
840.0
High
2,700.0
5 Year CAGR: 30.66 %
Low
575.0
High
2,700.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Caplin Point Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Caplin Point Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Caplin Point Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Caplin Point Laboratories Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Caplin Point Laboratories Ltd.?
The current share price of Caplin Point Laboratories Ltd. is ₹ 2,612.20 as of 17 Jul 2026.
What is the market capitalisation of Caplin Point Laboratories Ltd.?
The market capitalisation of Caplin Point Laboratories Ltd. stands at ₹ 19,855.90 Cr.
What is the PE ratio of Caplin Point Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Caplin Point Laboratories Ltd. is 30.96 as of the latest trailing twelve months data.
What is the ROE and ROCE of Caplin Point Laboratories Ltd.?
Caplin Point Laboratories Ltd. has a Return on Equity (ROE) of 19.89% and a Return on Capital Employed (ROCE) of 21.05% as per the latest financial reports.
What is the 52-week high and low of Caplin Point Laboratories Ltd.?
The 52-week high of Caplin Point Laboratories Ltd. is - and the 52-week low is -.
What is the dividend yield of Caplin Point Laboratories Ltd.?
The dividend yield of Caplin Point Laboratories Ltd. is 0.23% based on the current market price.
What is the FII and DII holding in Caplin Point Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 6.15%, Domestic Institutional Investors (DII) hold 2.03% and retail/public investors hold 19.61% of Caplin Point Laboratories Ltd. shares.
What sector does Caplin Point Laboratories Ltd. belong to?
Caplin Point Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Caplin Point Laboratories Ltd.?
The beta of Caplin Point Laboratories Ltd. is 0.94, indicating its price volatility relative to the broader market. Over the past 1 year, Caplin Point Laboratories Ltd. has delivered an absolute return of 28.59%.
What is the RSI of Caplin Point Laboratories Ltd.?
The 14-day Relative Strength Index (RSI) of Caplin Point Laboratories Ltd. is 61.05, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.